Home › Drug Codes › J Codes › J8503 · Aprepitant Injectable Emulsion
Upcoming code Effective Jan 1, 2027

Aprepitant Injectable Emulsion J Code: J8503

Injection, aprepitant (sandoz), 1 mg 505(b)(2)

Start 7-day free trial
Effective Date
Jan 1, 2027
Q1 2027 · not billable before
Medicare Payment Limit
Not yet published
CMS hasn’t priced J8503 yet
CMS Decision
New code
Third Quarter 2026
Billing Unit
1 mg
per HCPCS unit · from the CMS descriptor
NDCs
Not yet listed
Listed once CMS crosswalks J8503
Upcoming HCPCS Code · Effective January 1, 2027 CMS established J8503 in its Third Quarter 2026 HCPCS coding cycle. It is not valid on claims with dates of service before January 1, 2027. CMS has not yet published a payment limit for J8503.

Code Overview

HCPCS Descriptor (CMS) Injection, aprepitant (sandoz), 1 mg
Effective Date January 1, 2027
CMS Decision New code · Q3 2026 cycle
Manufacturer Sandoz
Route of Administration Intravenous
FDA Approval June 16, 2026 · 505(b)(2)

About Aprepitant Injectable Emulsion

Aprepitant Injectable Emulsion (aprepitant) is a product of Sandoz, given by the intravenous route. CMS has established J8503, a J Code for it, effective January 1, 2027.

J8503 Pricing

Effective Jan 1, 2027 No published pricing

J8503 is not yet effective and does not have published pricing.

No pricing-app account? Start a 7-day free trial · card required · cancel anytime

Code Timeline

  1. Third Quarter 2026 CMS establishes J8503 Published in the CMS HCPCS application summary.
  2. Jan 1, 2027 J8503 takes effect The code becomes billable. Aprepitant Injectable Emulsion’s launch date is set by its manufacturer and may come later.
  3. Once CMS has pricing data Medicare pricing CMS adds a payment limit to a quarterly ASP file. That can be the quarter the code takes effect or later.

Frequently Asked Questions

When can I start billing J8503?
For dates of service on or after January 1, 2027. A claim dated earlier with J8503 will deny. The effective date is when the code becomes valid, not necessarily when Aprepitant Injectable Emulsion is available.
What is the payment limit for J8503?
CMS has not published one yet. A new code gets a payment limit in a quarterly CMS ASP file once CMS has pricing data for the drug, which can be the quarter the code takes effect or later. Until then, Medicare contractors price claims individually.

Source: CMS HCPCS Application Summary, Third Quarter 2026 (PDF) . Code decisions are CMS’s; this page tracks them until the code takes effect.